PUBLICITY FOR THE ISSUE. 7.1 The Company agrees that, (i) during the restricted period, as described in the publicity guidelines/memorandum dated November 10, 2022 circulated by the legal counsel to appointed for the purpose of the Issue (“Publicity Memorandum”), they (i) have complied with at all times, and shall comply with, the Publicity Memorandum; (ii) shall not engage in publicity activities (including release by the Company of any Supplemental Offer Materials) that are not permitted under Applicable Law to the extent applicable to the Offer, in any jurisdiction, including SEBI ICDR Regulations, and (iii) shall ensure that their directors, employees, representatives and agents (as applicable) are aware of and comply with the Publicity Memorandum.
7.2 The Company agrees to obtain the prior written approval of the BRLMs in respect of all advertisements, press releases, publicity material or any other media communications in connection with the Issue and shall make available to the BRLMs copies of all such Issue related material, in each case during the restricted period under Clause 7.1 above.
7.3 Subject to Applicable Law, the BRLMs may, at their own expense place advertisements in newspapers and other external publications or pitch-books describing their involvement in the Issue and the services rendered by them, and may use the Company’s name(s) and logo(s) in this regard, and that the BRLMs may use the names and/ or logos, as applicable, of the Company with a prior written consent from the Company, which will be required only on a one-time basis (which will not be unreasonably withheld) for all advertisements and external publications. In relation to pitch-books and case studies prepared by the BRLMs, the BRLMs shall have the right to include the name and/or logo of the Company and their respective roles in the Issue and association with the Company in this regard, without any prior written consent from the Company. The BRLMs agree that any public advertisements shall be issued only after the date on which the Equity Shares being offered pursuant to the Issue are approved for trading on the Stock Exchanges and, in the event that approval for trading on each of the Stock Exchanges occurs on different dates, the later date shall be the relevant date for purposes of this Clause 7.3.
7.4 The Company has entered into an agreement with a press/advertising agency to monitor news reports, for the period between the date of filing the DRHP and the date of closure of the Issue, appe...
PUBLICITY FOR THE ISSUE. 6.1 The Company agrees that it has not and shall not, and that its respective Affiliates have not and shall not, during the restricted period, as set out in the publicity memorandum circulated by the legal counsel in relation to the Issue (the “Publicity Guidelines”), engage in any publicity activities that are not permitted under Applicable Law in any jurisdiction, including the SEBI ICDR Regulations and have complied with and shall at all times comply with the Publicity Guidelines and shall ensure that its Affiliates, directors, employees and representatives are aware of and comply with such Publicity Guidelines.
6.2 The Company and its Affiliates shall, during the restricted period under Clause 6.1 above, obtain the prior written consent of the BRLMs in respect of all advertisements, press releases, publicity material or any other media communications in connection with the Issue and shall make available to the BRLMs copies of all such Issue related material in advance of the proposed date of publication of such Issue related material.
6.3 The Company and its Affiliates shall comply with, and shall also ensure that any advertisements, press releases, publicity material or other communications comply with, all Applicable Law, including the SEBI ICDR Regulations and the Publicity Guidelines. The Company and its Affiliates shall not provide any additional or price sensitive information or make any statement or release any material or other information in any advertisements or any other form of publicity relating to the Issue, including:
(i) at any corporate, press, brokers’ or investors’ conferences in respect of the Issue;
(ii) in any interviews, blogs, posts on social media, by the directors, key managerial personnel, senior management or employees or representatives of the Company Entities;
(iii) in any documentaries about the Company Entities;
(iv) in any periodical reports or press releases; and
(v) to any person, including any research analyst in any manner whatsoever, including at road shows, presentations and in research or sales reports or at Bidding Centers, which is misleading or inaccurate or which is not disclosed in the Issue Documents, or that does not conform to Applicable Law, including the SEBI ICDR Regulations and the Publicity Guidelines.
6.4 The Company accepts full responsibility for the content of any announcement or any information contained in any document in connection with the Issue which the Company requests the BRLMs to issue ...
PUBLICITY FOR THE ISSUE. 10.1 The Company shall obtain prior approval of the Lead Managers and the legal counsel to the Issue in respect of all Issue advertisements and publicity material in connection with the Issue. The Company shall ensure that all publicity materials including advertisements prepared and released by the advertising agency or otherwise in connection with the Issue conform to the SEBI ICDR Regulations.
10.2 The Lead Managers may, at its own expense, but with prior written consent of the Company, which shall not be unreasonably withheld, place, advertisements in newspapers and other external publications describing their involvement in the Issue and the services rendered by them. The Lead Managers agree that such advertisements shall be issued only after the date on which the Rights Equity Shares are Allotted.
PUBLICITY FOR THE ISSUE. 6.1 Each of the Company and their respective Affiliates agree that it has not and shall not, during the period commencing from the date of the Draft Red Xxxxxxx Prospectus and ending 40 days after the date of the Prospectus, engage in any publicity activities prohibited under the SEBI ICDR Regulations and other Applicable Law and shall at all times comply with the publicity memorandum circulated by legal counsel in relation to the Issue and shall ensure that its directors, employees and representatives are aware of and comply with such guidelines. The Company also agrees that it will not, and its respective Affiliates will not engage in publicity activities in any other jurisdiction in which the Equity Shares under the Issue are being offered, during the period in which it is prohibited under the laws of each jurisdiction.
6.2 The Company and their respective Affiliates shall, during the restricted period under Section
PUBLICITY FOR THE ISSUE. 7.1 The Company agrees that, (i) during the restricted period, as described in the publicity guidelines/memorandum dated November 10, 2022 circulated by the legal counsel to appointed for the purpose of the Issue (“Publicity Memorandum”), they (i) have complied with at all times, and shall comply with, the Publicity Memorandum; (ii) shall not engage in publicity activities (including release by the Company of any Supplemental Offer Materials) that are not permitted under Applicable Law to the extent applicable to the Offer, in any jurisdiction, including SEBI ICDR Regulations, and (iii) shall ensure that their directors, employees, representatives and agents (as applicable) are aware of and comply with the Publicity Memorandum.
7.2 The Company agrees to obtain the prior written approval of the BRLMs in respect of all advertisements, press releases, publicity material or any other media communications in connection with the Issue and shall make available to the BRLMs copies of all such Issue related material, in each case during the restricted period under Clause 7.1 above.
7.3 Subject to Applicable Law, the BRLMs may, at their own expense place advertisements in newspapers and other external publications or pitch-books describing their involvement in the Issue and the services rendered by them, and may use the Company’s name(s) and logo(s) in this regard, and that the BRLMs may use the names and/ or logos, as applicable, of the Company with a prior written consent from the Company, which will be required only on a one-time basis (which will not be unreasonably withheld) for all advertisements and external publications. In relation to pitch-books and case studies prepared by the BRLMs, the BRLMs shall have the right to include the name and/or logo of the Company and their respective roles in the Issue and association with the Company in this regard, without any prior written consent from the Company. The BRLMs agree that any public advertisements shall be issued only after the date on which the Equity Shares being offered pursuant to the Issue are approved for trading on the Stock Exchanges and, in the event that approval for trading on each of the Stock Exchanges occurs on different dates, the later date shall be the relevant date for purposes of this Clause 7.3.
7.4 The Company has entered into an agreement with a press/advertising agency to monitor news reports, for the period between the date of filing the DRHP and the date of closure of the Issue, appe...
